Home Newsfeeds Report Twitter is Working on in-app Podcast Player

Report Twitter is Working on in-app Podcast Player

https://twitter.com/wongmjane/status/1544981108823310336

July 7, 2022

1 minute read

Twitter is working on in-app Podcast player https://t.co/HB2kd9k2CN pic.twitter.com/ACNafwmMfB

— Jane Manchun Wong (@wongmjane) July 7, 2022

UPDATE: Medifast Q4 Adj. EPS $3.70 Beats $2.22 Estimate, Sales $337.25M Beat $330.10M Estimate

By Happy Mohamed

February 21, 5:28 PM

Medifast (NYSE:MED) reported quarterly earnings of $3.70 per share which beat the analyst consensus estimate of $2.22 by 66.67 percent. This is a 27.15 percent increase over earnings of $2.91 per share from the same

MED

C4 Therapeutics Presents New Preclinical Data For CFT1946 Highlighting Superior Activity As A Single Agent To Clinically Approved BRAF Inhibitor Standard Of Care Combinations At The American Association For Cancer Research Annual Meeting 2024

By Benzinga Newsdesk

April 8, 8:25 AM

C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, presented a poster today at the American Association for Cancer Research

CCCC

Evaxion Biotech Announced Important Milestone Reached for EVX-01 Personalized Cancer Therapy

By Charles Gross

September 21, 5:46 AM

Evaxion Biotech A/S (NASDAQ: EVAX) reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01, the Company's personalized cancer therapy for the treatment of melanoma.

EVAX

Are Cracks Beginning To Form? Bank Of America Is Watching Credit Card Delinquencies Closely

By AJ Fabino

October 17, 1:37 PM

Bank of America Corp (NYSE: BAC) was out Monday with its current asset quality ratings.

BAC

Report Twitter is Working on in-app Podcast Player

Related Posts

UPDATE: Medifast Q4 Adj. EPS $3.70 Beats $2.22 Estimate, Sales $337.25M Beat $330.10M Estimate

C4 Therapeutics Presents New Preclinical Data For CFT1946 Highlighting Superior Activity As A Single Agent To Clinically Approved BRAF Inhibitor Standard Of Care Combinations At The American Association For Cancer Research Annual Meeting 2024

Evaxion Biotech Announced Important Milestone Reached for EVX-01 Personalized Cancer Therapy

Are Cracks Beginning To Form? Bank Of America Is Watching Credit Card Delinquencies Closely